ADPT Adaptive Biotechnologies Corp
Nasdaq · SEC CIK 1478320 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $122.01M 70 sales by 11 insiders
- Filings on record
- 204 since 2021-07-01, latest 2026-09-18 20:17
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| ROBINS HARLAN S | CSO | — | $29.65M |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| LO FRANCIS | CHRO | — | $13.21M |
| PISKEL KYLE | CFO | — | $3.58M |
| NEUPERT PETER M | Dir | — | $3.14M |
| GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 298
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-08 | 2023-03-06+ | ADPT | Taylor Stacy L | SVP, GC | S - Sale | $8.59 | -18.9K | 153.1K | -11% | -$162.2K |
| D | 2023-03-08 | 2023-03-06 | ADPT | Taylor Stacy L | SVP, GC | A - Grant | $0.00 | +85.7K | 158.6K | +118% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | PETERSON TYCHO | CFO | A - Grant | $0.00 | +118.2K | 492.9K | +32% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | Pellini Michael J | Dir | A - Grant | $0.00 | +14.8K | 23.0K | +180% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | RUBINSTEIN JULIE | Pres | A - Grant | $0.00 | +133.0K | 359.5K | +59% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | RUBINSTEIN JULIE | Pres | S - Sale | $8.57 | -22.7K | 336.8K | -6% | -$194.3K |
| D | 2023-03-08 | 2023-03-06 | ADPT | LO FRANCIS | CHRO | S - Sale | $8.57 | -6,816 | 168.5K | -4% | -$58.4K |
| D | 2023-03-08 | 2023-03-06 | ADPT | LO FRANCIS | CHRO | A - Grant | $0.00 | +85.7K | 175.3K | +96% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +14.8K | 23.0K | +180% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale | $8.57 | -11.7K | 223.8K | -5% | -$100.7K |
| D | 2023-03-08 | 2023-03-06 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | A - Grant | $0.00 | +133.0K | 235.6K | +130% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +14.8K | 76.0K | +24% | $0 |
| 2023-03-08 | 2023-03-06 | ADPT | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +354.6K | 666.6K | +114% | $0 | |
| M | 2023-03-08 | 2023-03-06 | ADPT | PISKEL KYLE | Principal Accounting Off | S - Sale | $8.57 | -3,529 | 87.6K | -4% | -$30.2K |
| 2023-03-08 | 2023-03-06 | ADPT | PISKEL KYLE | Principal Accounting Off | A - Grant | $0.00 | +43.7K | 91.1K | +92% | $0 | |
| D | 2023-02-03 | 2023-02-02 | ADPT | HERSHBERG ROBERT | Dir | M - OptEx | $0.45 | +53.0K | 61.2K | +647% | +$23.9K |
| M | 2023-01-11 | 2023-01-09+ | ADPT | ADAMS R MARK | COO | S - Sale | $8.55 | -3,125 | 115.6K | -3% | -$26.7K |
| A | 2022-11-17 | 2022-11-16 | ADPT | PISKEL KYLE | Principal Accounting Off | S - Sale | $8.87 | -307 | 47.4K | -0.6% | -$2,723 |
| 2022-11-17 | 2022-11-16 | ADPT | PISKEL KYLE | Principal Accounting Off | S - Sale | $8.87 | -959 | 46.7K | -2% | -$8,506 | |
| 2022-11-01 | 2022-11-01 | ADPT | SOOD NITIN | Chief Commercial Off, MRD | S - Sale | $8.00 | -31.1K | 114.5K | -21% | -$248.5K | |
| M | 2022-10-11 | 2022-10-07+ | ADPT | ADAMS R MARK | COO | S - Sale | $7.26 | -3,125 | 116.6K | -3% | -$22.7K |
| 2022-08-05 | 2022-08-05 | ADPT | SOOD NITIN | Chief Commercial Off, MRD | S - Sale | $10.98 | -17.5K | 145.6K | -11% | -$192.6K | |
| M | 2022-07-08 | 2022-07-07+ | ADPT | ADAMS R MARK | COO | S - Sale | $10.22 | -3,125 | 122.1K | -2% | -$31.9K |
| D | 2022-06-03 | 2022-06-01 | ADPT | PETERSON TYCHO | CFO | A - Grant | $0.00 | +374.7K | 374.7K | New | $0 |
| 2022-04-08 | 2022-04-07 | ADPT | ADAMS R MARK | COO | S - Sale | $13.17 | -831 | 122.9K | -0.7% | -$10.9K | |
| 2022-03-10 | 2022-03-08 | ADPT | Taylor Stacy L | SVP, GC | S - Sale | $11.44 | -2,387 | 72.9K | -3% | -$27.3K | |
| 2022-03-10 | 2022-03-08 | ADPT | LO FRANCIS | CHRO | S - Sale | $11.44 | -3,582 | 89.6K | -4% | -$41.0K | |
| 2022-03-10 | 2022-03-08 | ADPT | BALDO LANCE | Chief Medical Off | S - Sale | $11.43 | -3,350 | 17.2K | -16% | -$38.3K | |
| DM | 2022-03-09 | 2022-03-07+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | M - OptEx | $6.32 | -14.8K | 1.93M | -0.8% | -$93.6K |
| DM | 2022-03-09 | 2022-03-07+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale+OE | $11.80 | -44.4K | 1.92M | -2% | -$524.4K |
| D | 2022-03-08 | 2022-03-07 | ADPT | ADAMS R MARK | COO | S - Sale | $12.01 | -1,244 | 123.7K | -1.0% | -$14.9K |
| D | 2022-03-08 | 2022-03-04 | ADPT | ADAMS R MARK | COO | A - Grant | $0.00 | +74.1K | 125.0K | +146% | $0 |
| 2022-03-08 | 2022-03-04 | ADPT | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +247.1K | 1.92M | +15% | $0 | |
| 2022-03-08 | 2022-03-07 | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $12.01 | -4,424 | 1.92M | -0.2% | -$53.1K | |
| D | 2022-03-08 | 2022-03-07 | ADPT | BENZENO SHARON | Chief Business Development Off | S - Sale | $12.01 | -2,670 | 102.6K | -3% | -$32.1K |
| D | 2022-03-08 | 2022-03-04 | ADPT | BENZENO SHARON | Chief Business Development Off | A - Grant | $0.00 | +82.4K | 105.3K | +360% | $0 |
| D | 2022-03-08 | 2022-03-07 | ADPT | RUBINSTEIN JULIE | Pres | S - Sale | $12.01 | -4,613 | 226.5K | -2% | -$55.4K |
| D | 2022-03-08 | 2022-03-04 | ADPT | RUBINSTEIN JULIE | Pres | A - Grant | $0.00 | +185.3K | 231.1K | +405% | $0 |
| D | 2022-03-08 | 2022-03-04 | ADPT | PISKEL KYLE | Principal Accounting Off | A - Grant | $0.00 | +41.2K | 47.9K | +615% | $0 |
| D | 2022-03-08 | 2022-03-07 | ADPT | PISKEL KYLE | Principal Accounting Off | S - Sale | $12.01 | -220 | 47.7K | -0.5% | -$2,642 |
| D | 2022-03-08 | 2022-03-04 | ADPT | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +247.1K | 316.5K | +356% | $0 |
| D | 2022-03-08 | 2022-03-07 | ADPT | ROBINS HARLAN S | CSO | S - Sale | $12.01 | -4,517 | 312.0K | -1% | -$54.2K |
| D | 2022-03-08 | 2022-03-04 | ADPT | SOOD NITIN | Chief Commercial Off | A - Grant | $0.00 | +65.9K | 163.1K | +68% | $0 |
| D | 2022-03-08 | 2022-03-04 | ADPT | LO FRANCIS | CHRO | A - Grant | $0.00 | +74.1K | 94.7K | +360% | $0 |
| D | 2022-03-08 | 2022-03-07 | ADPT | LO FRANCIS | CHRO | S - Sale | $12.01 | -1,569 | 93.2K | -2% | -$18.8K |
| D | 2022-03-08 | 2022-03-07 | ADPT | Taylor Stacy L | SVP, GC | S - Sale | $12.01 | -1,569 | 75.2K | -2% | -$18.8K |
| D | 2022-03-08 | 2022-03-04 | ADPT | Taylor Stacy L | SVP, GC | A - Grant | $0.00 | +61.8K | 76.8K | +411% | $0 |
| 2022-03-08 | 2022-03-07 | ADPT | BALDO LANCE | Chief Medical Off | S - Sale | $12.01 | -2,373 | 20.5K | -10% | -$28.5K | |
| D | 2022-01-28 | 2022-01-26 | ADPT | Trigg Leslie | Dir | A - Grant | $0.00 | +6,689 | 11.1K | +151% | $0 |
| D | 2022-01-28 | 2022-01-26 | ADPT | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
| D | 2022-01-28 | 2022-01-26 | ADPT | Conroy Kevin T | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
| D | 2022-01-28 | 2022-01-26 | ADPT | OWEN KATEY EINTERZ | Dir | A - Grant | $0.00 | +6,689 | 11.1K | +151% | $0 |
| D | 2022-01-28 | 2022-01-26 | ADPT | NEUPERT PETER M | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
| D | 2022-01-28 | 2022-01-26 | ADPT | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
| D | 2022-01-28 | 2022-01-26 | ADPT | Pellini Michael J | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
| 2022-01-10 | 2022-01-07 | ADPT | ADAMS R MARK | COO | S - Sale | $23.32 | -1,021 | 50.8K | -2% | -$23.8K | |
| D | 2021-12-23 | 2021-12-22 | ADPT | Cohen Chad M | CFO | M - OptEx | $7.27 | +10.0K | 31.6K | +46% | +$72.7K |
| D | 2021-12-23 | 2021-12-22 | ADPT | Cohen Chad M | CFO | S - Sale+OE | $30.00 | -10.0K | 21.6K | -32% | -$300.0K |
| DM | 2021-12-23 | 2021-12-22 | ADPT | Taylor Stacy L | SVP, GC | M - OptEx | $6.97 | +15.3K | 25.2K | +156% | +$107.0K |
| D | 2021-12-23 | 2021-12-22 | ADPT | Taylor Stacy L | SVP, GC | S - Sale+OE | $30.00 | -15.3K | 15.0K | -50% | -$460.1K |
| DM | 2021-11-19 | 2021-11-17+ | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $32.00 | -4,000 | 69.4K | -5% | -$128.0K |
| DM | 2021-11-19 | 2021-11-17+ | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.55 | +4,000 | 69.7K | +6% | +$26.2K |
| D | 2021-11-17 | 2021-11-15 | ADPT | PISKEL KYLE | Principal Accounting Off | A - Grant | $0.00 | +3,837 | 6,699 | +134% | $0 |
| DM | 2021-11-12 | 2021-11-09+ | ADPT | Cohen Chad M | CFO | S - Sale+OE | $34.98 | -10.0K | 21.6K | -32% | -$349.8K |
| DM | 2021-11-12 | 2021-11-09+ | ADPT | Cohen Chad M | CFO | M - OptEx | $7.27 | +10.0K | 26.6K | +60% | +$72.7K |
| DM | 2021-10-21 | 2021-10-19+ | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $33.71 | -11.2K | 69.4K | -14% | -$377.6K |
| DM | 2021-10-21 | 2021-10-19+ | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.55 | +11.2K | 73.1K | +18% | +$73.4K |
| M | 2021-10-08 | 2021-10-07+ | ADPT | ADAMS R MARK | COO | S - Sale | $33.16 | -3,125 | 51.9K | -6% | -$103.6K |
| DM | 2021-10-08 | 2021-10-06+ | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $32.95 | -11.7K | 73.1K | -14% | -$385.0K |
| DM | 2021-10-08 | 2021-10-06+ | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +11.7K | 73.3K | +19% | +$73.8K |
| DM | 2021-10-07 | 2021-10-05+ | ADPT | Cohen Chad M | CFO | S - Sale+OE | $32.41 | -10.0K | 21.6K | -32% | -$324.1K |
| DM | 2021-10-07 | 2021-10-05+ | ADPT | Cohen Chad M | CFO | M - OptEx | $7.27 | +10.0K | 26.6K | +60% | +$72.7K |
| DM | 2021-09-15 | 2021-09-13+ | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +11.7K | 73.3K | +19% | +$73.8K |
| DM | 2021-09-15 | 2021-09-13+ | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $36.98 | -11.7K | 69.4K | -14% | -$432.1K |
| M | 2021-09-10 | 2021-09-08+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $38.43 | -43.5K | 1.67M | -3% | -$1.67M |
| DM | 2021-09-09 | 2021-09-07+ | ADPT | Cohen Chad M | CFO | M - OptEx | $6.80 | +14.4K | 26.6K | +118% | +$97.8K |
| DM | 2021-09-09 | 2021-09-07+ | ADPT | Cohen Chad M | CFO | S - Sale+OE | $39.47 | -14.4K | 21.6K | -40% | -$567.3K |
| D | 2021-09-09 | 2021-09-07 | ADPT | Taylor Stacy L | SVP, GC | M - OptEx | $6.55 | +495 | 15.5K | +3% | +$3,242 |
| D | 2021-09-09 | 2021-09-07 | ADPT | Taylor Stacy L | SVP, GC | S - Sale+OE | $40.00 | -495 | 15.0K | -3% | -$19.8K |
| D | 2021-08-30 | 2021-08-27 | ADPT | GRIFFIN MICHELLE RENEE | Dir | M - OptEx | $7.80 | +14.9K | 16.4K | +992% | +$116.3K |
| D | 2021-08-30 | 2021-08-27 | ADPT | GRIFFIN MICHELLE RENEE | Dir | S - Sale+OE | $35.00 | -14.9K | 1,504 | -91% | -$522.1K |
| DM | 2021-08-27 | 2021-08-25+ | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $34.25 | -11.7K | 69.4K | -14% | -$400.2K |
| DM | 2021-08-27 | 2021-08-25+ | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +11.7K | 73.3K | +19% | +$73.8K |
| D | 2021-08-18 | 2021-08-16 | ADPT | SOOD NITIN | Chief Commercial Off | A - Grant | $0.00 | +97.2K | 97.2K | New | $0 |
| DM | 2021-08-12 | 2021-08-10+ | ADPT | Cohen Chad M | CFO | S - Sale+OE | $34.07 | -15.0K | 21.6K | -41% | -$511.0K |
| DM | 2021-08-12 | 2021-08-10+ | ADPT | Cohen Chad M | CFO | M - OptEx | $6.55 | +15.0K | 31.6K | +90% | +$98.2K |
| DM | 2021-07-21 | 2021-07-19+ | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +11.7K | 73.3K | +19% | +$73.8K |
| DM | 2021-07-21 | 2021-07-19+ | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $37.47 | -11.7K | 72.0K | -14% | -$437.9K |
| D | 2021-07-19 | 2021-07-14 | ADPT | GRIFFIN MICHELLE RENEE | Dir | S - Sale+OE | $36.80 | -2,500 | 1,504 | -62% | -$92.0K |
| D | 2021-07-19 | 2021-07-14 | ADPT | GRIFFIN MICHELLE RENEE | Dir | M - OptEx | $7.80 | +2,500 | 4,004 | +166% | +$19.5K |
| D | 2021-07-19 | 2021-07-19 | ADPT | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | S - Sale+OE | $36.12 | -651 | 9,158 | -7% | -$23.5K |
| D | 2021-07-19 | 2021-07-19 | ADPT | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | M - OptEx | $22.55 | +651 | 9,809 | +7% | +$14.7K |
| 2021-07-14 | 2021-07-12 | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $38.24 | -1,501 | 1.72M | -0.1% | -$57.4K | |
| M | 2021-07-08 | 2021-07-07+ | ADPT | ADAMS R MARK | COO | S - Sale | $37.17 | -3,125 | 55.0K | -5% | -$116.2K |
| DM | 2021-07-08 | 2021-07-06+ | ADPT | Cohen Chad M | CFO | M - OptEx | $6.55 | +20.0K | 31.6K | +172% | +$131.0K |
| DM | 2021-07-08 | 2021-07-06+ | ADPT | Cohen Chad M | CFO | S - Sale+OE | $38.68 | -20.0K | 21.6K | -48% | -$773.6K |
| DM | 2021-07-01 | 2021-06-30 | ADPT | Taylor Stacy L | SVP, GC | S - Sale+OE | $41.42 | -4,167 | 15.4K | -21% | -$172.6K |
| DM | 2021-07-01 | 2021-06-30 | ADPT | Taylor Stacy L | SVP, GC | M - OptEx | $15.04 | +4,167 | 19.2K | +28% | +$62.7K |
Purchase Sale Sale after option exercise All abbreviations